argenx to Participate at Upcoming Investor Conferences
argenx (Euronext & Nasdaq: ARGX), a global immunology company, has announced its management team's participation in two upcoming investor conferences in November 2024. The company will participate in a fireside chat at the Guggenheim Inaugural Healthcare Innovation Conference on November 12 at 2:30 p.m. ET in Boston, and attend investor meetings at the Jefferies London Healthcare Conference on November 20-21 in London. A live webcast of the Guggenheim fireside chat will be available on the company's website, with a replay accessible for approximately 90 days.
argenx (Euronext & Nasdaq: ARGX), un'azienda globale nel campo dell'immunologia, ha annunciato la partecipazione del suo team di gestione a due conferenze per investitori in arrivo nel novembre 2024. L'azienda parteciperà a una chiacchierata informale durante la Guggenheim Inaugural Healthcare Innovation Conference il 12 novembre alle 14:30 ET a Boston e prenderà parte a incontri con investitori presso la Jefferies London Healthcare Conference il 20-21 novembre a Londra. Una diretta streaming della chiacchierata informale di Guggenheim sarà disponibile sul sito web dell'azienda, con una registrazione accessibile per circa 90 giorni.
argenx (Euronext & Nasdaq: ARGX), una empresa global de inmunología, ha anunciado la participación de su equipo directivo en dos conferencias de inversores programadas para noviembre de 2024. La compañía participará en una charla informal en la Guggenheim Inaugural Healthcare Innovation Conference el 12 de noviembre a las 2:30 p.m. ET en Boston, y asistirá a reuniones con inversores en la Jefferies London Healthcare Conference el 20 y 21 de noviembre en Londres. Una transmisión en vivo de la charla de Guggenheim estará disponible en el sitio web de la empresa, con una repetición accesible durante aproximadamente 90 días.
argenx (Euronext & Nasdaq: ARGX), 글로벌 면역학 회사로, 2024년 11월에 예정된 두 개의 투자자 컨퍼런스에 경영진이 참석할 것이라고 발표했습니다. 이 회사는 11월 12일 오후 2시 30분 ET에 보스턴에서 열리는 Guggenheim Inaugural Healthcare Innovation Conference에서 화기애애한 대화에 참여하며, 11월 20일부터 21일까지 런던에서 열리는 Jefferies London Healthcare Conference에 참석할 예정입니다. Guggenheim 화기애애한 대화의 생중계는 회사 웹사이트에서 제공되며, 약 90일 동안 재시청이 가능합니다.
argenx (Euronext & Nasdaq: ARGX), une entreprise mondiale dans le domaine de l'immunologie, a annoncé la participation de son équipe de direction à deux conférences pour investisseurs prévues en novembre 2024. L'entreprise participera à une discussion informelle lors de la Guggenheim Inaugural Healthcare Innovation Conference le 12 novembre à 14h30 ET à Boston, et assistera à des réunions avec des investisseurs lors de la Jefferies London Healthcare Conference les 20 et 21 novembre à Londres. Une diffusion en direct de la discussion informelle de Guggenheim sera disponible sur le site web de l'entreprise, avec un replay accessible pendant environ 90 jours.
argenx (Euronext & Nasdaq: ARGX), ein globales Unternehmen im Bereich Immunologie, hat die Teilnahme seines Management-Teams an zwei bevorstehenden Investorenkonferenzen im November 2024 angekündigt. Das Unternehmen wird am 12. November um 14:30 Uhr ET in Boston an einem Fireside-Chat auf der Guggenheim Inaugural Healthcare Innovation Conference teilnehmen und wird am 20. und 21. November in London Investorengespräche auf der Jefferies London Healthcare Conference führen. Ein Live-Stream des Guggenheim-Fireside-Chats wird auf der Webseite des Unternehmens verfügbar sein, mit einer Wiederholung, die etwa 90 Tage lang zugänglich ist.
- None.
- None.
November 5, 2024
Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of the management team will participate in the following upcoming investor conferences in November:
- Guggenheim Inaugural Healthcare Innovation Conference. Fireside chat on Tuesday, November 12, 2024 at 2:30 p.m. ET in Boston, MA.
- Jefferies London Healthcare Conference. Management will participate in investor meetings on Wednesday, November 20 and Thursday November 21, 2024 in London, UK.
A live webcast of the Guggenheim fireside chat may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately 90 days following the fireside chat.
About argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker, globally in the U.S., Japan, Israel, the EU, the UK, China and Canada. The Company is evaluating efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit www.argenx.com and follow us on LinkedIn, X/Twitter, Instagram, Facebook, and YouTube.
For further information, please contact:
Media:
Ben Petok
bpetok@argenx.com
Investors:
Alexandra Roy (US)
aroy@argenx.com
Lynn Elton (EU)
lelton@argenx.com
FAQ
When is argenx (ARGX) presenting at the Guggenheim Healthcare Innovation Conference 2024?
Which investor conferences is argenx (ARGX) attending in November 2024?
Where can I watch argenx's (ARGX) Guggenheim Conference presentation?
When is argenx (ARGX) participating in the Jefferies London Healthcare Conference 2024?
